Moreover, analysis of the TCGA dataset demonstrated a strong correlation between low FCN3 expression in HCC patients and poorer overall survival (p = 0.032) (Fig. S1C), as well as inferior disease-free survival (p = 0.0083) (Fig. S1D). The gene discussed is FCN3; the disease is hepatocellular carcinoma.